Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-31 @ 1:41 PM
Study NCT ID:
NCT05369351
Status:
RECRUITING
Last Update Posted:
2025-05-28
First Post:
2022-05-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Mirabegron in Intracerebral Hemorrhage
Sponsor:
Tianjin Medical University General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IRB2022-YX-073-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None